A Role for EZH2 in Silencing of IFN-γ Inducible MHC2TA Transcription in Uveal Melanoma

  • Holling T
  • Bergevoet M
  • Wilson L
  • et al.
58Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

We investigated the contribution of epigenetic mechanisms in MHC2TA transcriptional silencing in uveal melanoma. Although no correlation was observed between impaired CIITA transcript levels after IFN-γ induction and DNA methylation of MHC2TA promoter IV (CIITA-PIV), an association was found with high levels of trimethylated histone H3-lysine 27 (3Me-K27-H3) in CIITA-PIV chromatin. The 3Me-K27-H3 modification correlated with a strong reduction in RNA polymerase II-recruitment to CIITA-PIV. Interestingly, we observed that none of these epigenetic modifications affected recruitment of activating transcription factors to this promoter. Subsequently, we demonstrated the presence of the histone methyltransferase EZH2 in CIITA-PIV chromatin, which is known to be a component of the Polycomb repressive complex 2 and able to triple methylate histone H3-lysine 27. RNA interference-mediated down-regulation of EZH2 expression resulted in an increase in CIITA transcript levels after IFN-γ induction. Our data therefore reveal that EZH2 contributes to silencing of IFN-γ-inducible transcription of MHC2TA in uveal melanoma cells.

References Powered by Scopus

Role of histone H3 lysine 27 methylation in polycomb-group silencing

3097Citations
N/AReaders
Get full text

Genomic DNA methylation: The mark and its mediators

2049Citations
N/AReaders
Get full text

The Polycomb group protein EZH2 directly controls DNA methylation

1841Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study

496Citations
N/AReaders
Get full text

Biological consequences of MHC-II expression by tumor cells in cancer

316Citations
N/AReaders
Get full text

PRAME as an independent biomarker for metastasis in uveal melanoma

232Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Holling, T. M., Bergevoet, M. W. T., Wilson, L., Van Eggermond, M. C. J. A., Schooten, E., Steenbergen, R. D. M., … Van den Elsen, P. J. (2007). A Role for EZH2 in Silencing of IFN-γ Inducible MHC2TA Transcription in Uveal Melanoma. The Journal of Immunology, 179(8), 5317–5325. https://doi.org/10.4049/jimmunol.179.8.5317

Readers' Seniority

Tooltip

Researcher 14

58%

PhD / Post grad / Masters / Doc 8

33%

Professor / Associate Prof. 2

8%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 13

52%

Medicine and Dentistry 5

20%

Biochemistry, Genetics and Molecular Bi... 5

20%

Social Sciences 2

8%

Save time finding and organizing research with Mendeley

Sign up for free